Want to join the conversation?
Deutsche Bank analyst John Inch questions $HON whether the extra selling days seen in 1Q16 will have any discernible bearing on growth during 4Q16. CFO Thomas Szlosek says that it's reflected in the full-year 2016 guidance and the company has fully contemplated those factors. So, there is nothing discernible.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?